XSHG
605056
, Last price
Name
Xianheng International Science & Technology Co Ltd
Chart & performance
P/E
—
P/S
—
EPS
0.63
Vol. 1Y
—
Shs. 5Y
2.10%
Rev. 5Y
17.95%
Div Yld LY
—
Div Yld TTM
—
Revenues
4.54b
+26.03%
Net income
260m
+16.45%
CFO
569m
+96.91%
Dividend
Jun 02, 20260.31 /sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Xianheng International Science&Technology Co., Ltd. specializes in the development, production, and marketing of critical emergency rescue tools and essential supplies, primarily serving the electric power sector. The company's extensive product line encompasses a broad spectrum of specialized electrical construction equipment. This includes various tools for crimping, cutting, and processing busbars, hydraulic pumps, angle steel and screw processing devices, as well as products for cable handling, laying, and preparation, alongside railway-specific tools. Xianheng International also provides a wide range of lifting and access solutions, from mini cranes to a comprehensive assortment of aerial work platforms. These access solutions feature diverse models such as electric, self-propelled, diesel, and double-mast scissor lifts, mobile electric scissor lifts, self-propelled articulated and telescopic booms, sleeve-type platforms, super material lifts, and truck-mounted platforms. Further offerings include precision instruments like cable fault locators, bolt tensioners, hydraulic cylinders, and torque wrenches, complemented by a variety of lighting products. For manual tasks, they supply a full suite of hand tools, including insulated sets (both VDE compliant and general purpose). In addition to its industrial equipment, Xianheng International distributes vital personal protective and medical supplies. This category features disposable and medical face masks, protective respirators, non-contact thermometers, protective clothing, isolation gowns, gloves, goggles, and face shields. The company, established in 1989, is headquartered in Hangzhou, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||